Pharmaceutical Technology

FEBRUARY 28, 2023

It provides drugs for the treatment of cancer, cardiovascular diseases, dermatological conditions, neurological disorders, ophthalmic and respiratory diseases, hematologic diseases, solid tumors, immune disorders, and infections, among others. The company offers generic medicines and biosimilars through Sandoz.

Generic Pharmaceutical 172

Generic Pharmaceutical Dermatology Clinical Trials Clinical Trials 172

Pharmaceutical Technology

APRIL 19, 2023

“If approved, roflumilast foam would be the first topical drug with a new mechanism of action for this condition in over two decades, highlighting the unique formulation and deep dermatological expertise that Arcutis brings to immuno-dermatology.” in patients with seborrheic dermatitis.

Dermatology 130

Dermatology Trials Drugs Regulation 130

XTalks

AUGUST 14, 2024

In a press release video , Shawn Kwatra, MD, professor and chair of dermatology in the Department of Dermatology at the University of Maryland School of Medicine, explained that IL-31 is often referred to as the “master itch cytokine.”

Drug Delivery Systems 111

Drug Delivery Systems Dermatology Drug Delivery Antibody 111

Pharmaceutical Technology

APRIL 17, 2023

QPS is preparing the pre-investigational new drug applications to be submitted to the US Food and Drug Administration (FDA) and the EU’s European Medicines Agency (EMA) for the CannQuit and ReneCann products. French company Eurofins Scientific is currently developing and manufacturing both products.

Dermatology 130

Dermatology Clinical Trials Clinical Trials Production 130

XTalks

APRIL 17, 2023

These results are very promising for patients with atopic dermatitis,” said Jonathan Silverberg, MD, professor of dermatology at George Washington University School of Medicine & Health Sciences and co-investigator of the studies, in the company’s press release.

Dermatology 97

Dermatology Antibody Clinical Trials Clinical Trials 97

The Pharma Data

OCTOBER 29, 2020

Data support baricitinib’s ongoing Phase 3 program and potential to be the first approved medicine for people living with alopecia areata (AA). . The data underscore Lilly’s commitment to providing medicines for dermatologic diseases that have high unmet need, including alopecia areata (AA). INDIANAPOLIS , Oct.

Dermatology 52

Dermatology Development Medicine Clinical Trials 52

XTalks

AUGUST 2, 2023

Verrica Pharmaceuticals is a dermatology therapeutics company developing medications for skin diseases that require medical interventions. Tune into this episode to learn more about YCANTH and its approval, as well as the changing landscape of dermatology, from Dr. Eichenfield.

Life Science 52

Life Science FDA Approval Dermatology Pharmacy 52

FDA Law Blog

NOVEMBER 10, 2024

These have included clinical trials for rare diseases across metabolic (n=5), oncology (n=5), cardiology (n=3), dermatology (n=3), pulmonary (n=3), hematology (n=2), hepatology (n=2), ocular (n=2), transplant (n=1), gastrointestinal (n=1), immunology (n=1), infectious (n=1), neurology (n=1), orthopedic (n=1), and toxicology (n=1) indications.

Production 69

Production Clinical Development Development Regulation 69

STAT News

DECEMBER 2, 2022

Well, whatever you do, have a grand time. But be safe. Enjoy, and see you soon.

Clinical Trials 98

Clinical Trials Clinical Trials Trials Dermatology 98

XTalks

MAY 26, 2023

Results of the trials are published in the journals Nature Medicine and The New England Journal of Medicine. Peter Marinkovich, primary investigator of the GEM-3 trial, director of the Blistering Disease Clinic at Stanford Health Care and associate professor of dermatology at the Stanford University School of Medicine.

Gene Therapy 97

Gene Therapy Gene FDA Approval Dermatology 97

Pharmaceutical Technology

FEBRUARY 28, 2023

It provides drugs for the treatment of cancer, cardiovascular diseases, dermatological conditions, neurological disorders, ophthalmic and respiratory diseases, hematologic diseases, solid tumors, immune disorders, and infections, among others. The company offers generic medicines and biosimilars through Sandoz.

Generic Pharmaceutical 100

Generic Pharmaceutical Dermatology Clinical Trials Clinical Trials 100

Pharma in Brief

JULY 7, 2020

The Patented Medicine Prices Review Board ( PMPRB or Board ) has found that a patent can pertain to a medicine based on clinical similarities to the invention—even if the patent does not actually encompass the medicine. 2,478,237 (the 237 Patent ), which relates to the use of adapalene to treat dermatological disorders.

Medicine 40

Medicine Dermatology Containment Production 40

Pharmaceutical Technology

FEBRUARY 28, 2023

It provides drugs for the treatment of cancer, cardiovascular diseases, dermatological conditions, neurological disorders, ophthalmic and respiratory diseases, hematologic diseases, solid tumors, immune disorders, and infections, among others. The company offers generic medicines and biosimilars through Sandoz.

Generic Pharmaceutical 100

Generic Pharmaceutical Dermatology Drugs Clinical Trials 100

Pharmaceutical Technology

FEBRUARY 28, 2023

It provides drugs for the treatment of cancer, cardiovascular diseases, dermatological conditions, neurological disorders, ophthalmic and respiratory diseases, hematologic diseases, solid tumors, immune disorders, and infections, among others. The company offers generic medicines and biosimilars through Sandoz.

Generic Pharmaceutical 100

Generic Pharmaceutical Dermatology Drugs Clinical Trials 100

Pharmaceutical Technology

FEBRUARY 24, 2023

Its investigational medicinal products comprise R-107, R-131 and R-147. Douglas provides products in various therapeutic areas which include psoriasis, eczema, dermatitis, chicken pox, constipation, laxative, neonatal, hormone regulation, dermatology, cardiovascular and measles, among others.

Contract Manufacturing 100

Contract Manufacturing Dermatology Hormones Production 100

Pharmaceutical Technology

FEBRUARY 24, 2023

Its investigational medicinal products comprise R-107, R-131 and R-147. Douglas provides products in various therapeutic areas which include psoriasis, eczema, dermatitis, chicken pox, constipation, laxative, neonatal, hormone regulation, dermatology, cardiovascular and measles, among others.

Contract Manufacturing 100

Contract Manufacturing Dermatology Hormones Production 100

The Pharma Data

OCTOBER 1, 2021

The research, which spans clinical, health economics and outcomes research, translational, clinical pharmacology and preclinical presentations, highlights the breadth and depth of the company’s data on deucravacitinib, a first-in-class, oral, selective tyrosine kinase 2 (TYK2) inhibitor, also because the emerging dermatology pipeline.

Dermatology 52

Dermatology Trials Research Clinical Development 52

Rethinking Clinical Trials

SEPTEMBER 24, 2024

Mirza, MD, MPH Chief Resident Department of Dermatology Warren Alpert Medical School of Brown University Slides Keywords Artificial Intelligence; ChatGPT; Informed Consent Key Points Artificial Intelligence (AI), when implemented thoughtfully in clinical settings, can lead to meaningful results for patients.

Clinical Trials 100

Clinical Trials Clinical Trials Dermatology Trials 100

The Pharma Data

MAY 15, 2023

Positive data from two Phase 3 Dupixent ® (dupilumab) trials in prurigo nodularis published in Nature Medicine Positive results from two Phase 3 Dupixent ® (dupilumab) trials in adults with uncontrolled prurigo nodularis have been published in Nature Medicine. Gil Yosipovitch, M.D. There are about 75,000 and 70,000 adults in the U.S.

Medicine 40

Medicine Trials Dermatology FDA Approval 40

Scienmag

OCTOBER 19, 2020

One third of the cytotoxic killer cells in the liver as a potential therapeutic target Credit: MedUni Wien/Matern (Vienna, 19 October 2020) Good news for the human immune system: researchers from MedUni Vienna’s Departments of Dermatology and Surgery have managed to ascribe an immunological memory function to a subset of cytotoxic NK cells, which (..)

Dermatology 61

Dermatology Research Allergies Medicine 61

The Pharma Data

JUNE 2, 2023

Zouboulis, President of the European Hidradenitis Suppurativa Foundation, Director of the Departments of Dermatology, Venereology, Allergology and Immunology, Städtisches Klinikum Dessau, and Founding Professor of Dermatology and Venereology at the Brandenburg Medical School, Germany.

Dermatology 52

Dermatology Medicine Production Marketing 52

Scienmag

OCTOBER 28, 2020

Analysis of the largest registry of COVID-19 patients with dermatological symptoms has revealed a subset of patients, called ‘long-haulers’ or ‘long […].

Dermatology 54

Dermatology Medicine 54

The Pharma Data

NOVEMBER 29, 2021

Food and Drug Administration assigned a target action date of September 10, 2022; European Medicines Agency validation confirms the submission is complete and begins the centralized review process. The FDA has assigned a Tradition Medicine Stoner Figure Act (PDUFA) thing date of September 10, 2022.

Medicine 52

Medicine Drugs Dermatology Trials 52

Scienmag

JULY 7, 2021

Johns Hopkins Medicine study uncovers enzyme inhibitor that boosts immune system to fight MRSA and other dangerous skin infections Credit: National Institute of Allergy and Infectious Diseases, National Institutes of Health FOR IMMEDIATE RELEASE In what turned out to be one of the most important accidents of all time, Scottish bacteriologist Alexander (..)

Bacteria 97

Bacteria Allergies Medicine Dermatology 97

Scienmag

FEBRUARY 12, 2021

Acne treatment requires multidisciplinary approach, researchers say A more aggressive approach to treating acne that marries the disciplines of psychology and dermatology is needed, according to two UC Riverside psychology researchers. “Acne is pervasive, physically harmless, and painless, so […].

Dermatology 56

Dermatology Research Medicine 56

pharmaphorum

SEPTEMBER 8, 2022

The Digital Medicine Society (DiME) is today releasing a new set of open-access resources to advance the use of nocturnal scratch in the treatment of atopic dermatitis (AD). . It is hoped today’s event will serve as a “blueprint for the broader development and deployment of digital endpoints in medical product development”.

Dermatology 52

Dermatology Production Radiology Development 52

pharmaphorum

FEBRUARY 3, 2021

He also spent three years before that as Teva’s head of speciality medicines for Europe, and held previous senior roles at AstraZeneca, GSK and Eli Lilly. “Mr For the last three years he has served as executive vice president, growth markets commercial, at Israeli pharma Teva.

Dermatology 52

Dermatology Marketing Branding Medicine 52

Scienmag

JANUARY 25, 2021

Researchers at the George Washington University found that the majority of dermatology patients were comfortable with virtual visits as an alternative to in-person appointments WASHINGTON (Jan.

Dermatology 40

Dermatology Research Medicine 40

The Pharma Data

NOVEMBER 8, 2020

Almirall strengthens its leadership in medical dermatology by reinforcing its management team in France and obtaining reimbursement in France of Ilumetri ® (tildrakizumab) for treating moderate to severe chronic plaque psoriasis in adults. Dermatology shows resilience in Europe and initial signs of recovery in the US.

Dermatology 52

Dermatology Sales Marketing Production 52

XTalks

DECEMBER 15, 2020

Related: An Integrated Development Plan in Rare & Orphan Medicinal Products – Accelerating Time to Approval and Strengthening Asset Value. Synteract has a solid reputation in the emerging biopharma sphere, providing therapeutic expertise in areas including oncology, rare and orphan diseases, neuroscience, dermatology and pediatrics.

Dermatology 98

Dermatology Clinical Trials Clinical Trials Branding 98

Pharmaceutical Technology

APRIL 13, 2023

For some therapy areas, such as dermatology, recent improvements in remote video capture quality allows more accurate virtual assessments, and analysis shows [6] that nearly 24% of dermatology DCTs now incorporate this virtual component.

Clinical Trials 130

Clinical Trials Clinical Trials Trials Dermatology 130

XTalks

MAY 23, 2024

Companies specializing in dermatology and skincare have developed a range of products aimed at protecting the skin from harmful UV rays. In fact, tools such as dermatoscopes, digital imaging systems and artificial intelligence (AI)-powered diagnostic tools have become integral to dermatological practice.

Life Science 72

Life Science Dermatology Drug Delivery Systems Medicine 72

Scienmag

OCTOBER 28, 2020

The findings, presented at the 29th Congress of the European Academy of Dermatology and Venereology by investigators at Massachusetts […]. BOSTON – Some patients with COVID-19 have persistent skin-related symptoms long after their initial infection has cleared, according to a new analysis.

Dermatology 44

Dermatology Research Medicine 44

Pharmaceutical Technology

FEBRUARY 18, 2023

It provides drugs for the treatment of cancer, cardiovascular diseases, dermatological conditions, neurological disorders, ophthalmic and respiratory diseases, immune disorders, and infections, among others. The company offers generic medicines and biosimilars through Sandoz.

Generic Pharmaceutical 100

Generic Pharmaceutical Dermatology Antibody Development 100

Scienmag

DECEMBER 7, 2020

In a recent study published in the British Journal of Dermatology, individuals with atopic dermatitis, or eczema, were more likely to also have various autoimmune diseases, especially those involving the skin, the gastrointestinal tract, or the connective tissue.

Dermatology 42

Dermatology Research Allergies Medicine 42

Pharma in Brief

JANUARY 15, 2024

The Federal Court ( FC ) has refused to overturn a decision of the Patented Medicine Prices Review Board ( PMPRB or Board ) that found that a patent can pertain to a medicine based on “clinical similarities” to the invention—even if the patent does not actually encompass the medicine. The patentee, Galderma Canada Inc.

Dermatology 52

Dermatology Medicine Production Containment 52

pharmaphorum

MAY 20, 2022

There were accompanying improvements in medication use and reported quality-of-life scores in the study, which will be published in a peer-reviewed dermatology journal shortly, said the partners. Along with the Pfizer collaboration, it is also working with on an app/medicine combination for patients with peripheral artery disease.

Dermatology 69

Dermatology Development Medicine Marketing 69